Literature DB >> 10725623

Linac radiosurgery for cerebral arteriovenous malformations: results in 169 patients.

M Schlienger1, D Atlan, D Lefkopoulos, L Merienne, E Touboul, O Missir, F Nataf, H Mammar, K Platoni, P Grandjean, J N Foulquier, J Huart, C Oppenheim, J F Meder, E Houdart, J J Merland.   

Abstract

PURPOSE: To present the SALT group results using Linac radiosurgery (RS) for AVM in 169 evaluable patients treated from January 1990 thru December 1993. METHODS AND MATERIALS: Median age was 33 years (range 6-68 years). Irradiation was the only treatment in 55% patients. Other treatment modalities had been used prior to RS in 45%: one or more embolizations in 36%, surgery in 6%, and embolization and surgery in 3% patients. Nidus were supratentorial in 94% patients, infratentorial in 6% patients. Circular 15 MV x-ray minibeams (6-20 mm) were delivered in coronal arcs by a GE-CGR Saturne 43 Linac. Patient set-up included a Betti arm-chair, a Talairach frame. Prescribed peripheral dose was 25 Gy on the 60%-70% isodose (max dose 100%). Arteriographic results were reassessed in December 1997 at 48 to 96 months follow-up.
RESULTS: The overall obliteration rate (OR) was 64% (108/169). AVM volumes ranged from 280 to 19,920 mm(3), median 2460 mm(3). OR was 70% for AVM </= 4200 mm(3) 4200 mm(3) (p 25 mm (p = 0.04). OR was 71%, in the absence of embolization, vs. 54% for previously embolized nidus (p = 0.03). OR was 71% for monocentric RS vs. 54% for multi-isocenters (p 28 Gy vs. 55% for values </= 28 Gy (p 79% vs. 57% for lower values (p 17 Gy, vs. 59% for mLd </= 16 Gy (p 40%, vs. 54% for mLi </= 40% (p 85% vs. 60% for CR </= 84% (NS). For patients treated according to our protocol, i.e., 24-26 Gy on the 60%-70% isodoses, OR was higher (68%) than for other patients (47%) (p = 0.02). After multivariate analysis, absence of previous embolization and mono isocentric-irradiation were independent factors predicting obliteration. Complications were: recurrent hemorrhage, 4 patients (1 patient died); brain necrosis on MRI, 2 patients; subsequent epilepsy, 4 patients; other subsequent neurologic deficits, 3 patients.
CONCLUSION: Overall OR was 64% (48-96 months follow-up). After monovariate analysis higher ORs were associated with smaller volumes </= 4200 mm(3), smaller nidus size </= 25 mm, absence of prior embolization, monoisocentric RS, higher values for mean and minimum lesion doses and compliance to our protocol. Higher values for the peripheral dose and isodose tended to give better results. Multivariate analysis showed that the absence of prior embolization and monoisocentric irradiation were independent factors predicting successful irradiation.

Entities:  

Mesh:

Year:  2000        PMID: 10725623     DOI: 10.1016/s0360-3016(99)00523-4

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  12 in total

1.  Influence of intravenous contrast agent on dose calculation in 3-D treatment planning for radiosurgery of cerebral arteriovenous malformations.

Authors:  Angelika Zabel-du Bois; Benjamin Ackermann; Henrik Hauswald; Oliver Schramm; Gabriele Sroka-Perez; Peter Huber; Jürgen Debus; Stefanie Milker-Zabel
Journal:  Strahlenther Onkol       Date:  2009-05-15       Impact factor: 3.621

2.  Predictors of total obliteration in endovascular treatment of cerebral arteriovenous malformations.

Authors:  José Antonio Jordan; Juan Carlos Llibre; Frank Vazquez; Raul Marino Rodríguez
Journal:  Neuroradiol J       Date:  2014-02-24

Review 3.  Modern robot-assisted radiosurgery of cerebral angiomas-own experiences, system comparisons, and comprehensive literature overview.

Authors:  Thomas Feutren; Andres Huertas; Julia Salleron; René Anxionnat; Serge Bracard; Olivier Klein; Didier Peiffert; Valérie Bernier-Chastagner
Journal:  Neurosurg Rev       Date:  2017-11-05       Impact factor: 3.042

4.  Liquid embolization material reduces the delivered radiation dose: clinical myth or reality?

Authors:  F Bing; R Doucet; F Lacroix; J P Bahary; T Darsaut; D Roy; F Guilbert; J Raymond; A Weill
Journal:  AJNR Am J Neuroradiol       Date:  2011-12-22       Impact factor: 3.825

5.  Stereotactic radiosurgery of cerebral arteriovenous malformations: long-term follow-up in 164 patients of a single institution.

Authors:  Emmanouil Fokas; Martin Henzel; Andrea Wittig; Steffen Grund; Rita Engenhart-Cabillic
Journal:  J Neurol       Date:  2013-05-28       Impact factor: 4.849

6.  Retrospective analysis of linac-based radiosurgery for arteriovenous malformations and testing of the Flickinger formula in predicting radiation injury.

Authors:  I A Cetin; R Ates; J Dhaens; G Storme
Journal:  Strahlenther Onkol       Date:  2012-11-07       Impact factor: 3.621

7.  Prognostic factors for complete obliteration of arteriovenous malformations treated with LINAC-based stereotactic radiosurgery.

Authors:  Tim J Kruser; Wolfgang A Tome; Songwon Seo; John S Kuo; Patrick A Turski; Richard J Chappell; Rufus A Scrimger; Minesh P Mehta
Journal:  J Radiosurg SBRT       Date:  2011

8.  Long-term outcomes of 170 brain arteriovenous malformations treated by frameless image-guided robotic stereotactic radiosurgery: Ramathibodi hospital experience.

Authors:  Pritsana Punyawai; Nicha Radomsutthikul; Mantana Dhanachai; Chai Kobkitsuksakul; Ake Hansasuta
Journal:  Medicine (Baltimore)       Date:  2021-05-14       Impact factor: 1.889

9.  Embolization and radiosurgery for arteriovenous malformations.

Authors:  Andres R Plasencia; Alejandro Santillan
Journal:  Surg Neurol Int       Date:  2012-04-26

10.  The Role of Preradiosurgical Embolization in the Management of Grades III, IV, and V Arteriovenous Malformations.

Authors:  Evandro C Sousa; Manoel J Teixeira; Ronnie L Piske; Lavoisier S Albuquerque; Sebastião Côrrea; Salomão Benabou; Leonardo C Welling; Leonardo Moura de Sousa; Eberval Gadelha Figueiredo
Journal:  Front Surg       Date:  2016-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.